Forefront Analytics, LLC
13F Reported Value
ⓘ$92.0M
Holdings
37
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Forefront Analytics, LLC disclosed 37 positions worth $92.0M in its Form 13F-HR for Q2 2026. During the quarter the fund opened 0 new positions and exited 2. The portfolio is most concentrated in Other (75.5% of disclosed assets). All figures are sourced directly from Forefront Analytics, LLC’s Form 13F-HR filing with the SEC under CIK 1696802.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF
—Quality
$10.8M180,376 shISHARES TR - ESG AW MSCI EAFE
—Quality
$10.7M104,247 sh- $10.5M192,398 sh
ISHARES TR - CORE HIGH DV ETF
—Quality
$9.4M342,756 shISHARES TR - MSCI USA MMENTM
—Quality
$8.4M24,434 shNUSHARES ETF TR - NUVEEN ESG LRGVL
—Quality
$7.0M140,912 shDBX ETF TR - XTRACK MSCI EAFE
—Quality
$6.9M126,734 shFLEXSHARES TR - STOX GBL ESG SLT
—Quality
$5.1M21,669 sh- 85.9
Quality
$3.9M19,532 sh VANGUARD TAX-MANAGED FDS - VAN FTSE DEV MKT
—Quality
$3.4M47,559 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF | — | $10.8M | 180,376 |
| ISHARES TR - ESG AW MSCI EAFE | — | $10.7M | 104,247 |
| — | $10.5M | 192,398 | |
| ISHARES TR - CORE HIGH DV ETF | — | $9.4M | 342,756 |
| ISHARES TR - MSCI USA MMENTM | — | $8.4M | 24,434 |
| NUSHARES ETF TR - NUVEEN ESG LRGVL | — | $7.0M | 140,912 |
| DBX ETF TR - XTRACK MSCI EAFE | — | $6.9M | 126,734 |
| FLEXSHARES TR - STOX GBL ESG SLT | — | $5.1M | 21,669 |
| 85.9 | $3.9M | 19,532 | |
| VANGUARD TAX-MANAGED FDS - VAN FTSE DEV MKT | — | $3.4M | 47,559 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Forefront Analytics, LLC's 37 positions.
Showing top 10 of 37 holdings.
Sector Allocation
Other
$69.5M
Financials
$12.6M
Technology
$4.6M
Healthcare
$4.3M
Industrials
$743,196
Consumer Staples
$264,600
Full Holdings — Forefront Analytics, LLC (Q2 2026)
All 37 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF | $10.8M | 11.7% | +0% | — |
| 2 | — | ISHARES TR - ESG AW MSCI EAFE | $10.7M | 11.7% | -59% | — |
| 3 | MITSUBISHI UFJ FINANCIAL GROUP INC | $10.5M | 11.4% | -48% | — | |
| 4 | — | ISHARES TR - CORE HIGH DV ETF | $9.4M | 10.2% | +403% | — |
| 5 | — | ISHARES TR - MSCI USA MMENTM | $8.4M | 9.1% | +1% | — |
| 6 | — | NUSHARES ETF TR - NUVEEN ESG LRGVL | $7.0M | 7.7% | -28% | — |
| 7 | — | DBX ETF TR - XTRACK MSCI EAFE | $6.9M | 7.5% | -0% | — |
| 8 | — | FLEXSHARES TR - STOX GBL ESG SLT | $5.1M | 5.5% | -51% | — |
| 9 | NVIDIA CORP | $3.9M | 4.3% | +37% | 85.9 | |
| 10 | — | VANGUARD TAX-MANAGED FDS - VAN FTSE DEV MKT | $3.4M | 3.7% | +1% | — |
| 11 | — | ISHARES TR - CORE S&P500 ETF | $3.3M | 3.6% | -1% | — |
| 12 | — | ISHARES INC - CUR HD MSCI EM | $2.6M | 2.8% | -1% | — |
| 13 | JPMORGAN CHASE & CO | $1.6M | 1.8% | +0% | 70.7 | |
| 14 | DEERE & CO | $743,196 | 0.8% | +3% | 55.4 | |
| 15 | UNITEDHEALTH GROUP INC | $585,796 | 0.6% | -29% | 62.7 | |
| 16 | INCYTE CORP | $577,116 | 0.6% | +20% | 77.4 | |
| 17 | Edwards Lifesciences Corp | $557,053 | 0.6% | -6% | 69.4 | |
| 18 | — | PROSHARES TR - PSHS ULT S&P 500 | $551,159 | 0.6% | +0% | — |
| 19 | — | PROSHARES TR - PSHS ULTRUSS2000 | $537,666 | 0.6% | +0% | — |
| 20 | ABBOTT LABORATORIES | $514,078 | 0.6% | +12% | 65.5 | |
| 21 | WisdomTree, Inc. | $475,886 | 0.5% | -15% | 59.9 | |
| 22 | PFIZER INC | $438,489 | 0.5% | +39% | 62 | |
| 23 | Medtronic plc | $416,108 | 0.5% | +0% | 68.7 | |
| 24 | DANAHER CORP /DE/ | $388,506 | 0.4% | +58% | 64.8 | |
| 25 | THERMO FISHER SCIENTIFIC INC. | $335,619 | 0.4% | +16% | 65.1 | |
| 26 | Blue Owl Technology Finance Corp. | $306,919 | 0.3% | +0% | — | |
| 27 | Legend Biotech Corp | $305,204 | 0.3% | -33% | 47.8 | |
| 28 | Philip Morris International Inc. | $264,600 | 0.3% | +1% | 75.9 | |
| 29 | REGENERON PHARMACEUTICALS, INC. | $258,830 | 0.3% | -10% | 71 | |
| 30 | — | SCHWAB STRATEGIC TR - US DIVIDEND EQ | $243,406 | 0.3% | -49% | — |
| 31 | — | VANGUARD INDEX FDS - VALUE ETF | $236,319 | 0.3% | -18% | — |
| 32 | Zura Bio Ltd | $159,111 | 0.2% | +81% | — | |
| 33 | GERON CORP | $113,637 | 0.1% | +61% | — | |
| 34 | CytomX Therapeutics, Inc. | $93,874 | 0.1% | +101% | 8.7 | |
| 35 | BICYCLE THERAPEUTICS PLC | $92,525 | 0.1% | +52% | — | |
| 36 | Nkarta, Inc. | $81,943 | 0.1% | -34% | — | |
| 37 | Annexon, Inc. | $81,310 | 0.1% | +0% | — |
Exited Positions (2)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Forefront Analytics, LLC including:
Track Forefront Analytics, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Forefront Analytics, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Forefront Analytics, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Forefront Analytics, LLC (SEC CIK: 1696802), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Forefront Analytics, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.